CC 📈 Chemours - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1638511089
CC: Pigments, Refrigerants, Resins, Solvents, Coatings, Membranes
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware. Web URL: https://www.chemours.com
Additional Sources for CC Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CC Stock Overview
Market Cap in USD | 3,260m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception | 2015-07-01 |
CC Stock Ratings
Growth 5y | 3.30% |
Fundamental | -4.41% |
Dividend | 51.3% |
Rel. Strength Industry | -4089 |
Analysts | 3.6/5 |
Fair Price Momentum | 15.81 USD |
Fair Price DCF | 32.21 USD |
CC Dividends
Dividend Yield 12m | 5.77% |
Yield on Cost 5y | 6.95% |
Annual Growth 5y | 0.00% |
Payout Consistency | 79.5% |
CC Growth Ratios
Growth Correlation 3m | -7.7% |
Growth Correlation 12m | -84.3% |
Growth Correlation 5y | 29% |
CAGR 5y | 3.78% |
CAGR/Mean DD 5y | 0.16 |
Sharpe Ratio 12m | -0.72 |
Alpha | -89.75 |
Beta | 1.79 |
Volatility | 44.06% |
Current Volume | 1161.9k |
Average Volume 20d | 1804.3k |
What is the price of CC stocks?
As of December 27, 2024, the stock is trading at USD 17.33 with a total of 1,161,898 shares traded.
Over the past week, the price has changed by -0.80%, over one month by -20.94%, over three months by -15.59% and over the past year by -44.14%.
As of December 27, 2024, the stock is trading at USD 17.33 with a total of 1,161,898 shares traded.
Over the past week, the price has changed by -0.80%, over one month by -20.94%, over three months by -15.59% and over the past year by -44.14%.
Is Chemours a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Chemours is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CC as of December 2024 is 15.81. This means that CC is currently overvalued and has a potential downside of -8.77%.
Neither. Based on ValueRay Fundamental Analyses, Chemours is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CC as of December 2024 is 15.81. This means that CC is currently overvalued and has a potential downside of -8.77%.
Is CC a buy, sell or hold?
Chemours has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CC.
Chemours has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CC.
- Strong Buy: 2
- Buy: 2
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecast for CC stock price target?
According to ValueRays Forecast Model, CC Chemours will be worth about 17.2 in December 2025. The stock is currently trading at 17.33. This means that the stock has a potential downside of -0.81%.
According to ValueRays Forecast Model, CC Chemours will be worth about 17.2 in December 2025. The stock is currently trading at 17.33. This means that the stock has a potential downside of -0.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 23.8 | 37.2% |
Analysts Target Price | 37.9 | 118.6% |
ValueRay Target Price | 17.2 | -0.8% |